|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Provision for credit losses | |||||
| (Credit) provision for unfunded commitments | |||||
| Depreciation and amortization | |||||
| Net amortization (accretion) of securities | |||||
| Available for sale security losses | |||||
| Realized gains on equity securities | |||||
| Gain on debt extinguishment | |||||
| Losses on premises and equipment sales and disposals, net | |||||
| Stock compensation expense | |||||
| Earnings on bank owned life insurance | |||||
| Income recognized from death benefit on bank owned life insurance | |||||
| Origination of loans held for sale | |||||
| Proceeds from loans held for sale | |||||
| Net gains on sale of loans | |||||
| Net change in other assets and liabilities | |||||
| NET CASH FROM OPERATING ACTIVITIES | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Proceeds from maturities and repayments of securities available for sale | |||||
| Proceeds from sales of securities available for sale | |||||
| Purchases of securities available for sale | |||||
| Proceeds from maturities and repayments of SBIC funds | |||||
| Purchases of SBIC funds | |||||
| Proceeds from sale of equity securities | |||||
| SBIC Funds | |||||
| Total proceeds from sale of equity securities | |||||
| Purchases of equity securities | |||||
| SBIC Funds | |||||
| Total purchases of equity securities | |||||
| Purchases of restricted stock | |||||
| Proceeds from redemption of restricted stock | |||||
| Loan originations and payments, net | |||||
| Purchase of portfolio loans | |||||
| Proceeds from loans held for sale previously classified as portfolio loans | |||||
| Proceeds from BOLI death benefit | |||||
| Purchase of company owned life insurance | |||||
| Proceeds from land and building sales | |||||
| Additions to premises and equipment | |||||
| Net cash paid in business combinations | |||||
| NET CASH (USED IN) FROM INVESTING ACTIVITIES | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Net change in deposits | |||||
| Net change in short-term borrowings | |||||
| Repayments of long-term borrowings | |||||
| Proceeds from long term borrowings | |||||
| Redemption of subordinated debentures | |||||
| Cash dividends paid | |||||
| Cash paid for withholding taxes on share-based awards | |||||
| Repurchase of common shares | |||||
| NET CASH FROM (USED IN) FINANCING ACTIVITIES | |||||
| NET CHANGE IN CASH AND CASH EQUIVALENTS | |||||
| Beginning cash and cash equivalents | |||||
| Ending cash and cash equivalents | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental noncash disclosures: | |||||
| Issuance of stock for business combinations | |||||
| Issuance of stock awards | |||||
| Transfer of loans to loans held for sale | |||||
| Lease liabilities assumed from obtaining right-of-use assets | |||||
Loading...